NYSE: AMWL - American Well Corporation

Yield per half year: -12.85%
Dividend yield: 0.00%
Sector: Healthcare

Share chart American Well Corporation


About American Well Corporation

American Well Corporation предоставляет приложение для телемедицины, которое соединяет поставщиков, страховщиков, пациентов и новаторов и позволяет им предоставлять доступ к услугам здравоохранения. Его применение предлагает неотложную помощь; педиатрия; терапия; питание при климаксе; консультирование по поводу менопаузы; телестройка; управление здоровьем населения; телепсихиатрия; беременность и послеродовое питание; беременность и послеродовая терапия; поддержка грудного вскармливания; уход за климаксом; беременность и послеродовой уход; и услуги по лечению хромовых заболеваний.

more details
Компания также предоставляет оборудование для телемедицины, включая тележки для телемедицины, периферийные устройства и киоски. Его приложение доступно в App Store и Google Play. American Well Corporation была основана в 2006 году и базируется в Бостоне, штат Массачусетс. У него есть дополнительные офисы в Рестоне, Вирджиния; Сиэтл, Вашингтон; и Рамат-Ган, Израиль.

IPO date 2020-09-17
ISIN US03044L1052
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://amwell.com
Цена ао 8.14
Change price per day: 0% (8.14)
Change price per week: -4.8% (8.55)
Change price per month: -29.03% (11.47)
Change price per 3 month: -9.25% (8.97)
Change price per half year: -12.85% (9.34)
Change price per year: -56.84% (18.86)
Change price per 3 year: +94.27% (4.19)
Change price per 5 year: 0% (8.14)
Change price per 10 year: 0% (8.14)
Change price per year to date: +12.28% (7.25)

Underestimation

Title Value Grade
P/S 1.67 8
P/BV 0.8998 9
P/E 6.92 10
EV/EBITDA -0.3274 0
Total: 7.13

Efficiency

Title Value Grade
ROA, % -114.49 0
ROE, % -145.44 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0537 10
Total: 7.4

Growth impulse

Title Value Grade
Yield Revenue, % 73.97 8
Yield Ebitda, % 160.06 10
Yield EPS, % 9040.62 10
Total: 9.4

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
31.12.2024 31.12.2024 Kurt Knight
Officer
Purchase 7.1 109 794 15464 0 0.01 link
31.12.2024 31.12.2024 Kathy Weiler
Officer
Purchase 7.1 205 126 28891 0 0.01 link
17.07.2023 18.07.2023 Paunovich Vukasin
EVP, Enterprise Platforms
Sale 2.16 226 437 104832 0 -0.05 link
21.06.2023 22.06.2023 Schoenberg Roy
President, co-CEO
Sale 2.19 275 274 125696 0 -0.06 link
21.06.2023 22.06.2023 Schoenberg Ido
Chairman, co-CEO
Sale 2.19 297 476 135834 0 -0.06 link
13.06.2023 15.06.2023 Slavin Peter L.
Director
Sale 2.51 56 902 22670 0 -0.01 link
01.05.2023 02.05.2023 McNeice Paul Francis
Vice President of Accounting
Sale 2.17 265 122 0 0 link
01.05.2023 02.05.2023 Knight Kurt
Chief Operating Officer
Sale 2.17 12 098 5575 0 0 link
01.05.2023 02.05.2023 Gotlib Phyllis
President, International
Sale 2.17 9 674 4458 0 0 link
21.03.2023 23.03.2023 Schoenberg Roy
President, co-CEO
Sale 2.4 272 846 113686 0 -0.05 link
21.03.2023 23.03.2023 Schoenberg Ido
Chairman, co-CEO
Sale 2.4 326 899 136208 0 -0.06 link
06.03.2023 08.03.2023 Knight Kurt
Chief Operating Officer
Sale 2.73 70 106 25680 0 -0.01 link
27.01.2023 31.01.2023 Gay Bradford
Senior VP, General Counsel
Sale 3.96 47 995 12120 0 -0.01 link
18.01.2023 18.01.2023 Gay Bradford
Senior VP, General Counsel
Sale 3.96 5 148 1300 0 0 link
17.01.2023 18.01.2023 Gay Bradford
Senior VP, General Counsel
Sale 3.95 395 100 0 0 link
13.01.2023 18.01.2023 Gay Bradford
Senior VP, General Counsel
Sale 3.95 2 765 700 0 0 link
06.09.2022 08.09.2022 Knight Kurt
Chief Operating Officer
Sale 4.37 109 910 25151 0 -0.01 link
01.07.2022 06.07.2022 Schoenberg Ido
Chairman, co-CEO
Sale 4.39 1 317 000 300000 0 -0.13 link
15.06.2022 16.06.2022 Jackson Deborah C
Director
Sale 4.07 27 037 6643 0 0 link
15.06.2022 16.06.2022 Schlegel Stephen J.
Director
Sale 4.13 20 873 5054 0 0 link
01.03.2022 03.03.2022 Gotlib Phyllis
President, International
Sale 4.04 55 550 13750 0 -0.01 link
01.03.2022 03.03.2022 Knight Kurt
Chief Operating Officer
Sale 4.07 72 690 17860 0 -0.01 link
17.09.2021 22.04.2022 Cosgrove Delos M.
Director
Purchase 18 3 600 200 0 0 link
17.09.2021 22.04.2022 OGrady Brendan P.
See Remarks
Purchase 18 252 000 14000 0 0.01 link
17.09.2021 22.04.2022 PATRICK DEVAL L
Director
Purchase 18 144 000 8000 0 0 link
17.09.2021 22.04.2022 PATRICK DEVAL L
Director
Purchase 18 54 000 3000 0 0 link
17.09.2021 22.04.2022 Schlegel Stephen J.
Director
Purchase 18 360 000 20000 0 0.01 link

Institutions Volume Share, %
Senvest Management LLC 23529964 9.18
Blackrock Inc. 21512979 8.39
Caledonia (Private) Investments Pty Ltd 17297672 6.75
Vanguard Group Inc 13207174 5.15
Alerce Investment Management, L.P. 10475717 4.09
Morgan Stanley 7628752 2.98
Geode Capital Management, LLC 5593175 2.18
State Street Corporation 4762819 1.86
Renaissance Technologies, LLC 3058800 1.19
Millennium Management LLC 2822624 1.1



Head Job title Payment Year of birth
Mr. Kurt Knight Chief Operating Officer 905.39k 1979 (46 years)
Ms. Phyllis I. Gotlib President of Amwell International 1M 1958 (67 years)
Mr. Paul Francis McNeice Vice President of Accounting N/A 1977 (48 years)
Mr. Robert Shepardson Chief Financial Officer 910.51k 1965 (60 years)
Dr. Ido Schoenberg M.D. Chairman & CEO 1.52M 1965 (60 years)
Ms. Sue Dooley Head of Investor Relations N/A
Mr. Vukasin Paunovich Executive Vice President of Enterprise Platforms 910.73k 1972 (53 years)
Mr. Bradford F. Gay Senior VP & General Counsel N/A 1977 (48 years)
Dr. Roy Schoenberg M.D., M.P.H. Executive Vice Chairman 1.4M 1969 (56 years)
Ms. Kathy Weiler Executive VP and Chief Commercial & Growth Officer 1970 (55 years)

Address: United States, Boston, MA , 75 State Street - open in Google maps, open in Yandex maps
Website: http://amwell.com